From a more affordable diabetes drug to a surprising cancer connection at home, here's what's making health headlines today.

This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat various cancers and autoimmune conditions such as rheumatoid arthritis and ...

U.S. market will not open until patent expires in 2032, but individual generics can be sold in Canada once approved ...

Generic dapagliflozin is indicated to lower heart failure hospitalization risk in type 2 diabetes with established ...

The FDA approves Apotex Corp.’s plan to introduce generic Ozempic, a semaglutide injection that one study suggests could ...

The FDA approved the first generic dapagliflozin tablets, opening a competitive US market for pharma manufacturers and ...

Generic dapagliflozin is now approved for adults with type 2 diabetes, though current labeling excludes chronic kidney disease and pediatric use.

Teva Pharmaceutical must face a lawsuit claiming it used unlawful methods to block generic competition for its multiple ...

Affordable, regulated versions of Ozempic, the well-known diabetes and weight-loss shot from Novo Nordisk, are about to hit markets around the world, which could shake up the obesity drug scene. The ...

Officials with the FDA have approved the first generic omeprazole oral paste for the treatment of gastric ulcers and ...